Sitting at Work Increases Your Chance of Dying

The word of the day is "stalemate". Last year the Republicans had a chance to accept spending cuts to tax hikes at a 10-1 ratio. They declined. Now president Obama does not want to bargain. Who can blame Obama (except Republicans)? We may disagree, but that is part of the platform that got him elected. The Republicans do not want to bargain either. And who can blame them (except Democrats)? Regardless, Republicans blew a golden opportunity last year and that chance is gone. Obama has the upper hand now, and nothing will change that setup.

It is not easy running in black dress shoes. Especially when it is January and the sidewalks are a slushy mess, and especially when you are 36-years-old and wearing dress pants in addition to dress shoes, and not merely out for a casual jog but sprinting, flat-out, like Florence Griffith Joyner, circa 1988, in hot pursuit of a teenager with the physique of a high school football player who had just kicked in a glass door at the fitness club where you work as the manager.

Former Goldman Sachs vice president Matt Levine, who is now an editor for popular financial blog Dealbreaker, has been writing a column for NPR's Planet Money called "Ask A Banker."

Calgary was stunned when 56-year-old Wong Shuk Yee was struck by a car in the northwest Calgary suburbs on Wednesday. The driver drove off, the following two cars swerved around her body and continued on, and then Ms. Wong was hit by a second car that dragged her a short ways and then also continued on. Ms. Yee died at the scene, comforted only by Tonja Beach, a mother of four who lived nearby. No other cars pulled over, Ms. Beach said. No one else came to help. The driver of the first car eventually pulled over and called police.

CIBC has become the new bank of no surprises Chief Executive Officer Gerald McCaughey’s mission to reduce risk at Canadian Imperial Bank of Commerce is rewarding shareholders with a less-volatile stock that’s beating its peers.

By Stephen Simpson:There aren't too many medical device companies out there with legitimately exciting pipelines, but St. Jude Medical (STJ) is one of them. With intriguing products in development across almost all of its operational groups, St. Jude could be looking at a significant revenue growth opportunity in the next three to five years.

By Scott Matusow:In this article, I list 5 biopharmas that have huge upside potential, but are very high risk and have equally as large downside potential. Exposure to these stocks need careful consideration by investors.

ISIS Pharmaceuticals, Inc. (ISIS) Update On Its Metabolic Franchise Conference Call December 7, 2012 12:00 pm ET Executives Stanley Crooke - Chairman of the Board, President, Chief Executive Officer Wade Walke - Executive Director, Corporate Communications and Investor Relations Sanjay Bhanot - Vice President, Clinical Development and Translational Medicine